Crossmark

Neurocognitive functioning, seizure control, and return to work after awake surgery with or without adjuvant therapy in IDH-mutant grade 3 diffuse gliomas

Crossref DOI link: https://doi.org/10.1007/s11060-026-05526-2

Published Online: 2026-03-13

Published Print: 2026-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Elia, Angela

Roux, Alexandre

Demasi, Marco

Debacker, Clément

Seneca, Maïmiti

Dezamis, Edouard

De France, Gonzague

Trancart, Bénédicte

Muto, Jun

Oppenheim, Catherine

Chrétien, Fabrice

Zanello, Marc

Pallud, Johan
License Information

Text and Data Mining valid from 2026-03-01

Version of Record valid from 2026-03-01
More Information

Article History

Received: 24 January 2026

Accepted: 10 March 2026

First Online: 13 March 2026

Declarations

:

: The study protocol was approved by the local institutional review board (Protocol number A01933-48). The manuscript was written according to the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) checklist [ ].

: The authors declare no competing interests.

Document is current

Any future updates will be listed below